COST-EFFECTIVENESS (CE) OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX VERSUS PROTHROMBIN COMPLEX CONCENTRATE (PCC) IN THE TREATMENT OF HEMOPHILIA-B PATIENTS UNDERGOING KNEE SURGERY
B. Djulbegovic, COST-EFFECTIVENESS (CE) OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX VERSUS PROTHROMBIN COMPLEX CONCENTRATE (PCC) IN THE TREATMENT OF HEMOPHILIA-B PATIENTS UNDERGOING KNEE SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 1036-1036